• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶的抑制促进人乳腺癌细胞中DNA甲基转移酶1的泛素依赖性蛋白酶体降解。

Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells.

作者信息

Zhou Qun, Agoston Agoston T, Atadja Peter, Nelson William G, Davidson Nancy E

机构信息

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans Street, CRB Room 144, Baltimore, MD 21231, USA.

出版信息

Mol Cancer Res. 2008 May;6(5):873-83. doi: 10.1158/1541-7786.MCR-07-0330.

DOI:10.1158/1541-7786.MCR-07-0330
PMID:18505931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3361136/
Abstract

Histone deacetylases (HDAC) play a critical role in chromatin modification and gene expression. Recent evidence indicates that HDACs can also regulate functions of nonhistone proteins by catalyzing the removal of acetylated lysine residues. Here, we show that the HDAC inhibitor LBH589 down-regulates DNA methyltransferase 1 (DNMT1) protein expression in the nucleus of human breast cancer cells. Cotreatment with the proteasomal inhibitor MG-132 abolishes the ability of LBH589 to reduce DNMT1, suggesting that the proteasomal pathway mediates DNMT1 degradation on HDAC inhibition. Deletion of the NH(2)-terminal 120 amino acids of DNMT1 diminishes LBH589-induced ubiquitination, indicating that this domain is essential for its proteasomal degradation. DNMT1 recruits the molecular chaperone heat shock protein 90 (Hsp90) to form a chaperone complex. Treatment with LBH589 induces hyperacetylation of Hsp90, thereby inhibiting the association of DNMT1 with Hsp90 and promoting ubiquitination of DNMT1. In addition, inactivation of HDAC1 activity by small interfering RNA and MS-275 is associated with Hsp90 acetylation in conjunction with reduction of DNMT1 protein expression. We conclude that the stability of DNMT1 is maintained in part through its association with Hsp90. Disruption of Hsp90 function by HDAC inhibition is a unique mechanism that mediates the ubiquitin-proteasome pathway for DNMT1 degradation. Our studies suggest a new role for HDAC1 and identify a novel mechanism of action for the HDAC inhibitors as down-regulators of DNMT1.

摘要

组蛋白去乙酰化酶(HDAC)在染色质修饰和基因表达中发挥关键作用。最近的证据表明,HDAC还可通过催化去除乙酰化赖氨酸残基来调节非组蛋白的功能。在此,我们表明HDAC抑制剂LBH589可下调人乳腺癌细胞核中DNA甲基转移酶1(DNMT1)的蛋白表达。与蛋白酶体抑制剂MG-132共同处理可消除LBH589降低DNMT1的能力,这表明蛋白酶体途径介导了HDAC抑制作用下DNMT1的降解。删除DNMT1的NH(2)末端120个氨基酸可减少LBH589诱导的泛素化,表明该结构域对其蛋白酶体降解至关重要。DNMT1招募分子伴侣热休克蛋白90(Hsp90)形成伴侣复合物。用LBH589处理可诱导Hsp90的高乙酰化,从而抑制DNMT1与Hsp90的结合并促进DNMT1的泛素化。此外,小干扰RNA和MS-275使HDAC1活性失活与Hsp90乙酰化以及DNMT1蛋白表达降低相关。我们得出结论,DNMT1的稳定性部分通过其与Hsp90的结合得以维持。HDAC抑制作用破坏Hsp90功能是介导DNMT1降解的泛素-蛋白酶体途径的独特机制。我们的研究揭示了HDAC1的新作用,并确定了HDAC抑制剂作为DNMT1下调剂的新作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/8a471c7cb829/nihms343899f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/b73ac05a530d/nihms343899f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/05d1c6ebcc7f/nihms343899f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/c8dbe73d059f/nihms343899f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/16978f642db9/nihms343899f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/ff5d1002be5a/nihms343899f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/8a471c7cb829/nihms343899f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/b73ac05a530d/nihms343899f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/05d1c6ebcc7f/nihms343899f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/c8dbe73d059f/nihms343899f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/16978f642db9/nihms343899f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/ff5d1002be5a/nihms343899f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8720/3361136/8a471c7cb829/nihms343899f6.jpg

相似文献

1
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells.组蛋白去乙酰化酶的抑制促进人乳腺癌细胞中DNA甲基转移酶1的泛素依赖性蛋白酶体降解。
Mol Cancer Res. 2008 May;6(5):873-83. doi: 10.1158/1541-7786.MCR-07-0330.
2
5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.5-氮杂脱氧胞苷通过一种蛋白酶体途径诱导DNA甲基转移酶1的选择性降解,该途径需要KEN框、溴邻同源结构域和核定位信号。
Mol Cell Biol. 2005 Jun;25(11):4727-41. doi: 10.1128/MCB.25.11.4727-4741.2005.
3
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.帕比司他治疗可降低EZH2和DNMT1水平,并增强地西他滨介导的对JunB的去抑制作用以及人急性白血病细胞的存活丧失。
Cancer Biol Ther. 2009 May;8(10):939-50. doi: 10.4161/cbt.8.10.8213. Epub 2009 May 18.
4
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.组蛋白去乙酰化酶抑制剂LBH589可重新激活沉默的雌激素受体α(ER)基因表达,而不会导致DNA超甲基化缺失。
Cancer Biol Ther. 2007 Jan;6(1):64-9. doi: 10.4161/cbt.6.1.3549.
5
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.组蛋白脱乙酰酶抑制剂LBH589与热休克蛋白90抑制剂17-AAG联合使用对具有FLT-3激活突变的人慢性粒细胞白血病急变期细胞和急性髓细胞白血病细胞具有高活性。
Blood. 2005 Feb 15;105(4):1768-76. doi: 10.1182/blood-2004-09-3413. Epub 2004 Oct 28.
6
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.组蛋白去乙酰化酶6的抑制作用使热休克蛋白90乙酰化并破坏其伴侣功能:组蛋白去乙酰化酶抑制剂抗白血病活性的新基础。
J Biol Chem. 2005 Jul 22;280(29):26729-34. doi: 10.1074/jbc.C500186200. Epub 2005 Jun 2.
7
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion.热休克蛋白90α的乙酰化作用及细胞外定位在肿瘤细胞侵袭中的作用
Cancer Res. 2008 Jun 15;68(12):4833-42. doi: 10.1158/0008-5472.CAN-08-0644.
8
DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination.DNMT1 的稳定性受到协调去泛素化和乙酰化驱动泛素化的蛋白质的调节。
Sci Signal. 2010 Nov 2;3(146):ra80. doi: 10.1126/scisignal.2001462.
9
The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.泛素-蛋白酶体通路与癌症中的表观遗传修饰。
Anticancer Agents Med Chem. 2021;21(1):20-32. doi: 10.2174/1871520620666200811114159.
10
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.组蛋白去乙酰化酶抑制剂与阿扎胞苷联合对食管癌细胞的选择性抑制作用
Epigenetics. 2015;10(5):431-45. doi: 10.1080/15592294.2015.1039216.

引用本文的文献

1
The hydroxamate based HDAC inhibitor WMJ-J-09 induces colorectal cancer cell death by targeting tubulin and downregulating survivin.基于异羟肟酸的组蛋白去乙酰化酶抑制剂WMJ-J-09通过靶向微管蛋白和下调生存素诱导结肠癌细胞死亡。
Sci Rep. 2025 Jun 4;15(1):19590. doi: 10.1038/s41598-025-04714-w.
2
The scaffolding function of LSD1 controls DNA methylation in mouse ESCs.LSD1 的支架功能控制着小鼠胚胎干细胞中的 DNA 甲基化。
Nat Commun. 2024 Sep 5;15(1):7758. doi: 10.1038/s41467-024-51966-7.
3
HSP90 multi-functionality in cancer.HSP90 在癌症中的多功能性。
Front Immunol. 2024 Aug 1;15:1436973. doi: 10.3389/fimmu.2024.1436973. eCollection 2024.
4
Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer.DNA甲基转移酶(DNMT)和组蛋白去乙酰化酶(HDAC)双重抑制剂通过诱导病毒模拟物来引发乳腺癌的抗肿瘤免疫反应。
Cell Death Discov. 2024 Mar 15;10(1):143. doi: 10.1038/s41420-024-01895-7.
5
Synthetic Curcumin Analogs in the Treatment of Cancer: A Literature Review.合成姜黄素类似物在癌症治疗中的应用:文献综述
Curr Med Chem. 2024 Jan 23. doi: 10.2174/0109298673256932231123151626.
6
Enzymology of Mammalian DNA Methyltransferases.哺乳动物DNA甲基转移酶的酶学
Adv Exp Med Biol. 2022;1389:69-110. doi: 10.1007/978-3-031-11454-0_4.
7
Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein.乳腺癌及其治疗中的激素和遗传调控事件:类固醇生成急性调节蛋白的重要性
Biomedicines. 2022 Jun 3;10(6):1313. doi: 10.3390/biomedicines10061313.
8
Acetylated DNMT1 Downregulation and Related Regulatory Factors Influence Metastatic Melanoma Patients Survival.乙酰化DNMT1下调及相关调控因子影响转移性黑色素瘤患者的生存。
Cancers (Basel). 2021 Sep 18;13(18):4691. doi: 10.3390/cancers13184691.
9
Critical Roles of Calpastatin in Ischemia/Reperfusion Injury in Aged Livers.钙蛋白酶抑制蛋白在老年肝脏缺血/再灌注损伤中的关键作用。
Cells. 2021 Jul 23;10(8):1863. doi: 10.3390/cells10081863.
10
Histone Deacetylase Inhibitor SAHA Induces Expression of Fatty Acid-Binding Protein 4 and Inhibits Replication of Human Cytomegalovirus.组蛋白去乙酰化酶抑制剂 SAHA 诱导脂肪酸结合蛋白 4 的表达并抑制人巨细胞病毒的复制。
Virol Sin. 2021 Dec;36(6):1352-1362. doi: 10.1007/s12250-021-00382-y. Epub 2021 Jun 22.

本文引用的文献

1
The Hsp90 molecular chaperone: an open and shut case for treatment.热休克蛋白90(Hsp90)分子伴侣:治疗的一个成败关键案例。
Biochem J. 2008 Mar 15;410(3):439-53. doi: 10.1042/BJ20071640.
2
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.组蛋白去乙酰化酶抑制剂LBH589可重新激活沉默的雌激素受体α(ER)基因表达,而不会导致DNA超甲基化缺失。
Cancer Biol Ther. 2007 Jan;6(1):64-9. doi: 10.4161/cbt.6.1.3549.
3
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.乳腺癌转移抑制因子1(BRMS1)由热休克蛋白90(Hsp90)伴侣蛋白稳定。
Biochem Biophys Res Commun. 2006 Oct 6;348(4):1429-35. doi: 10.1016/j.bbrc.2006.08.005. Epub 2006 Aug 10.
4
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies.一项针对难治性血液系统恶性肿瘤患者的Ⅰ期研究,该研究使用新型肉桂异羟肟酸类似物组蛋白去乙酰化酶抑制剂静脉注射LBH589。
Clin Cancer Res. 2006 Aug 1;12(15):4628-35. doi: 10.1158/1078-0432.CCR-06-0511.
5
Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation.组蛋白去乙酰化酶8保护人类端粒不断缩短蛋白1B(hEST1B)免受泛素介导的降解。
Mol Cell Biol. 2006 Jul;26(14):5259-69. doi: 10.1128/MCB.01971-05.
6
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.雌激素受体阴性乳腺癌细胞中他莫昔芬敏感性的恢复:与他莫昔芬结合的重新激活的雌激素受体招募独特的共抑制复合物。
Cancer Res. 2006 Jun 15;66(12):6370-8. doi: 10.1158/0008-5472.CAN-06-0402.
7
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.组蛋白去乙酰化酶抑制剂LBH589是一种有效的抗骨髓瘤药物,可克服耐药性。
Cancer Res. 2006 Jun 1;66(11):5781-9. doi: 10.1158/0008-5472.CAN-05-4186.
8
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.组蛋白去乙酰化酶抑制剂诱导缺氧诱导因子1α的VHL和不依赖泛素的蛋白酶体降解。
Mol Cell Biol. 2006 Mar;26(6):2019-28. doi: 10.1128/MCB.26.6.2019-2028.2006.
9
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?癌症中的表观遗传基因沉默——早期致癌途径成瘾的一种机制?
Nat Rev Cancer. 2006 Feb;6(2):107-16. doi: 10.1038/nrc1799.
10
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.用组蛋白去乙酰化酶抑制剂靶向肿瘤血管生成:异羟肟酸衍生物LBH589。
Clin Cancer Res. 2006 Jan 15;12(2):634-42. doi: 10.1158/1078-0432.CCR-05-1132.